Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence of Covid-19-Like Symptoms Among People Living With Hiv, and Using Antiretroviral Therapy for Prevention and Treatment Publisher Pubmed



Seyedalinaghi S1 ; Ghadimi M2 ; Hajiabdolbaghi M1 ; Rasoolinejad M1 ; Abbasian L1 ; Nezhad MH3 ; Manshadi SD1 ; Ghadimi F1 ; Ahmadinejad Z4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, 600 N Wolfe St, Room 143, Baltimore, 21287, MD, United States
  3. 3. Department of Infectious Diseases, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Liver Transplantation Research Center, Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Source: Current HIV Research Published:2020


Abstract

Background: COVID-19 has spread globally with remarkable speed, and currently, there is limited data available exploring any aspect of the intersection between HIV and SARSCoV-2 co-infection. Objective: To estimate the prevalence of clinical symptoms associated with COVID-19 among people living with HIV (PLWH) in Tehran, Iran. Design: Cross-sectional study. Methods: A total of 200 PLWH were recruited through the positive club via sampling, and completed the symptom-based questionnaire for COVID-19, which was delivered by trained peers. Results: Of 200 participants, respiratory symptoms, including cough, sputum, and shortness of breath, were the most prevalent among participants, but only one person developed symptoms collectively suggested COVID-19 and sought treatments. Conclusion: It appears that existing infection with HIV or receiving antiretroviral treatment (ART) might reduce the susceptibility to the infection with SARS-CoV-2 or decrease the severity of the infection acquired. Further research is needed to understand causal mechanisms. © 2020 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
2. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
3. Factors Associated With Covid-19 Morbidity and Mortality: A Narrative Review, Journal of Iranian Medical Council (2020)
4. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
5. Biomarker Based Biosensors: An Opportunity for Diagnosis of Covid-19, Reviews in Medical Virology (2022)
6. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
7. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)
8. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (16)
Seyed Ahmad Seyed Alinaghi (9)
Other Related Docs
9. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
10. Cardiovascular Disease in Covid-19: A Systematic Review and Meta-Analysis of 10,898 Patients and Proposal of a Triage Risk Stratification Tool, Egyptian Heart Journal (2020)
11. The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran, International Journal of Hematology-Oncology and Stem Cell Research (2023)
12. Current Treatments and Therapeutic Options for Covid-19 Patients: A Systematic Review, Infectious Disorders - Drug Targets (2022)
13. The Prophylaxis and Treatment Potential of Supplements for Covid-19, European Journal of Pharmacology (2020)
14. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
15. Corona Virus Disease 2019 (Covid-19) As a System-Level Infectious Disease With Distinct Sex Disparities, Frontiers in Immunology (2021)
16. Vaccines for Covid-19: A Systematic Review of Feasibility and Effectiveness, Infectious Disorders - Drug Targets (2022)
17. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
18. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
19. A Randomized Clinical Trial of the Efficacy and Safety of Interferon Β-1A in Treatment of Severe Covid-19, Antimicrobial Agents and Chemotherapy (2020)
20. Auxiliary Role of Mesenchymal Stem Cells As Regenerative Medicine Soldiers to Attenuate Inflammatory Processes of Severe Acute Respiratory Infections Caused by Covid-19, Cell and Tissue Banking (2020)
21. The Clinical Value of Two Combination Regimens in the Management of Patients Suffering From Covid-19 Pneumonia: A Single Centered, Retrospective, Observational Study, DARU# Journal of Pharmaceutical Sciences (2020)
22. Covid-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. an International Society of Addiction Medicine Practice and Policy Interest Group Position Paper, Basic and Clinical Neuroscience (2020)
23. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
24. Proinflammatory and Immunomodulatory Cytokine Mrna Changes by Real-Time Rt-Pcr in Patients With Covid-19 Hospitalization in the Icu and People Recovering From the Disease, Minerva Pneumologica (2020)
25. Acute Pericarditis As the Primary Presentation of Covid-19 Infection Followed by Guillain-Barre Syndrome in a Healthy Young Man: A Case Report, Open Respiratory Medicine Journal (2022)
26. Immune Checkpoint Inhibition in Covid-19: Risks and Benefits, Expert Opinion on Biological Therapy (2021)
27. All About Covid-19 in Brief, New Microbes and New Infections (2020)
28. Mesenchymal Stem Cell Therapies for Covid-19: Current Status and Mechanism of Action, Life Sciences (2020)
29. Pharmacotherapeutic Considerations in Solid Organ Transplant Patients With Covid-19, Expert Opinion on Pharmacotherapy (2020)
30. Orrelation Between Type Ii Diabetes and Left Heart Function Utility of the Right Ventricular Early Inflow-Out Flow Index in the Assessment of Mortality in Covid-19 Bayat Et Al, Iranian Heart Journal (2021)
31. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)
32. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)
33. The Emerging Role of Micrornas in the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection, International Immunopharmacology (2021)
34. Impact of Sars-Cov-2 Pandemic on Patients With Primary Immunodeficiency, Journal of Clinical Immunology (2021)
35. Exploring the Causes of Mild Covid-19 Involvement in Pediatric Patients, New Microbes and New Infections (2020)
36. Th17 and Treg Cells Function in Sars-Cov2 Patients Compared With Healthy Controls, Journal of Cellular Physiology (2021)
37. Cytokine Profiles Dynamics in Covid-19 Patients: A Longitudinal Analysis of Disease Severity and Outcomes, Scientific Reports (2025)
38. Risk Factors of Death in Mechanically Ventilated Covid-19 Patients: A Multi-Center Study From Iran, Acta Medica Iranica (2023)
39. State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2, ACS Applied Materials and Interfaces (2021)
40. Pathophysiological Clues to How the Emergent Sars-Cov-2 Can Potentially Increase the Susceptibility to Neurodegeneration, Molecular Neurobiology (2021)
41. The Comparison of Clinical, Laboratory, and Radiological Findings in Immunocompromised and Immunocompetent Patients With Covid-19: A Case-Control Study, Immunity# Inflammation and Disease (2023)
42. The Prognostic Value of Comorbidity for the Severity of Covid-19: A Systematic Review and Meta-Analysis Study, PLoS ONE (2021)
43. Efficacy and Safety of Sofosbuvir/ Ledipasvir in Treatment of Patients With Covid-19; a Randomized Clinical Trial, Acta Biomedica (2020)
44. Determine the Most Common Clinical Symptoms in Covid-19 Patients: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2020)
45. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
46. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
47. Cardiac Complications in Covid-19: A Systematic Review and Meta-Analysis, Archives of Iranian Medicine (2021)
48. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
49. Thrombotic Storm in Coronavirus Disease 2019: From Underlying Mechanisms to Its Management, Journal of Medical Microbiology (2022)
50. The Relationship of Covid-19 Severity With Laboratory Findings and Neutrophil-To-Lymphocyte Ratio in Patients Admitted to a Large Teaching Hospital in Iran: A Cross-Sectional Study, Health Science Reports (2024)